Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro
Authors:
- Meera G NairMNMeera G Nair
- Daniel W CochraneDCDaniel W Cochrane
- Judith E AllenJAJudith E Allen
- 1 January 2003
- journal article
- Published by Elsevier in Immunology Letters
- Vol. 85 (2) , 173-180
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Chronic Helminth Infection Induces Alternatively Activated Macrophages Expressing High Levels of CCR5 with Low Interleukin-12 Production and Th2-Biasing AbilityInfection and Immunity, 2002
- Expression of the Ym2 Lectin-binding Protein Is Dependent on Interleukin (IL)-4 and IL-13 Signal TransductionJournal of Biological Chemistry, 2001
- FIZZ1, a novel cysteine‐rich secreted protein associated with pulmonary inflammation, defines a new gene familyThe EMBO Journal, 2000
- Other Functions, Other GenesImmunity, 1999
- Genetic Characterization of the Murine Ym1 Gene and Identification of a Cluster of Highly Homologous GenesGenomics, 1998
- APC from mice harbouring the filarial nematode, Brugia malayi, prevent cellular proliferation but not cytokine productionInternational Immunology, 1996
- Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow‐derived macrophages by TH 1 and TH 2 cytokinesEuropean Journal of Immunology, 1995
- Granulocyte apoptosis and the control of inflammationPhilosophical Transactions of the Royal Society B: Biological Sciences, 1994
- Interleukin‐13 alters the activation state of murine macrophages in vitro: Comparison with interleukin‐4 and interferon‐γEuropean Journal of Immunology, 1994
- Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.Journal of Experimental Medicine, 1992